The newest HPV vaccine safely and effectively prevents at least four different kinds of cancer in the population recommended to receive it, according to a study in Pediatrics today. Gardasil […]

BLOOMFIELD, Conn.–(BUSINESS WIRE)–Cigna Corporation (NYSE:CI) confirmed today it received a highly conditional, non-binding proposal from Anthem, Inc. (NYSE: ANTM) on June 20, 2015. Cigna’s Board of Directors has carefully reviewed […]

Anthem (ANTM) today went public with its takeover bid for Cigna Corp. (CI) offering the global health insurer $184 per share in cash and stock, according to a statement from the […]

INDIANAPOLIS–(BUSINESS WIRE)–Anthem, Inc. (NYSE: ANTM) today announced that it has submitted a non-binding proposal to acquire Cigna Corporation (NYSE: CI) for $184 per share in cash and stock. The proposed […]

State Republican leaders are ratcheting up the pressure on Congress to overhaul the Affordable Care Act if the Supreme Court this month rules that subsidies on the federal exchange are […]

Results are in from Lions Health 2015, taking place June 19th-20th in Cannes, France. Cannes Lions is the world’s largest yearly awards show and festival for professionals in the creative […]

NEW YORK–(BUSINESS WIRE)–The Center for Medicine in the Public Interest (CMPI) today criticized a so-called cost calculator for cancer medications as inaccurate and potentially dangerous. An article in the Wall […]

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced that the European Commission has approved Opdivo, a PD-1 immune checkpoint inhibitor, for the treatment of advanced (unresectable or metastatic) melanoma in […]

Effort With CDC to Collect, Analyze and Disseminate Much-Needed Sickle Cell Information ATLANTA, GA–(Marketwired – June 19, 2015) – Sickle cell disease (SCD), estimated to affect nearly 100,000 Americans, is […]

JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it has completed the purchase of 4.61 percent of all outstanding shares of Mylan N.V. (NASDAQ: MYL), which […]